227 related articles for article (PubMed ID: 8388584)
21. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome.
Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM
Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489
[TBL] [Abstract][Full Text] [Related]
22. Living related liver transplantation: histopathologic analysis of graft dysfunction in 304 patients.
Minamiguchi S; Sakurai T; Fujita S; Okuno T; Haga H; Mino M; Kanehira K; Matsushiro H; Nakashima Y; Inomata Y; Tanaka K; Yamabe H
Hum Pathol; 1999 Dec; 30(12):1479-87. PubMed ID: 10667427
[TBL] [Abstract][Full Text] [Related]
23. Changes in the expression of major histocompatibility complex class II antigens in liver allograft rejection.
Hubscher SG; Adams DH; Elias E
J Pathol; 1990 Oct; 162(2):165-71. PubMed ID: 2250195
[TBL] [Abstract][Full Text] [Related]
24. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
[TBL] [Abstract][Full Text] [Related]
25. Major histocompatibility complex antigens in human liver transplants.
Steinhoff G
J Hepatol; 1990 Jul; 11(1):9-15. PubMed ID: 2204660
[TBL] [Abstract][Full Text] [Related]
26. HLA-A,B and DR matching in corneal transplantation.
Boisjoly HM; Roy R; Dubé I; Laughrea PA; Michaud R; Douville P; Heébert J
Ophthalmology; 1986 Oct; 93(10):1290-7. PubMed ID: 3537887
[TBL] [Abstract][Full Text] [Related]
27. Role of HLA compatibility in pediatric liver transplantation.
Francavilla R; Hadzic N; Underhill J; Heaton N; Rela M; Mieli-Vergani G; Donaldson P
Transplantation; 1998 Jul; 66(1):53-8. PubMed ID: 9679822
[TBL] [Abstract][Full Text] [Related]
28. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
[TBL] [Abstract][Full Text] [Related]
29. Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching.
Smith JD; Rose ML; Pomerance A; Burke M; Yacoub MH
Lancet; 1995 Nov; 346(8986):1318-22. PubMed ID: 7475769
[TBL] [Abstract][Full Text] [Related]
30. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival.
Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD
Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130
[TBL] [Abstract][Full Text] [Related]
31. Clinical use of immunohistopathologic methods for the diagnosis of cytomegalovirus hepatitis in human liver allograft biopsy specimens.
Barkholt LM; Ehrnst A; Veress B
Scand J Gastroenterol; 1994 Jun; 29(6):553-60. PubMed ID: 8079116
[TBL] [Abstract][Full Text] [Related]
32. Impact of human leukocyte antigen matching in liver transplantation.
Neumann UP; Guckelberger O; Langrehr JM; Lang M; Schmitz V; Theruvath T; Schonemann C; Menzel S; Klupp J; Neuhaus P
Transplantation; 2003 Jan; 75(1):132-7. PubMed ID: 12544885
[TBL] [Abstract][Full Text] [Related]
33. Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft-rejection episodes and cytomegalovirus infection.
van Es A; Baldwin WM; Oljans PJ; Tanke HJ; Ploem JS; van Es LA
Transplantation; 1984 Jan; 37(1):65-9. PubMed ID: 6320508
[TBL] [Abstract][Full Text] [Related]
34. Persistent cytomegalovirus in liver allografts with chronic rejection.
Lautenschlager I; Höckerstedt K; Jalanko H; Loginov R; Salmela K; Taskinen E; Ahonen J
Hepatology; 1997 Jan; 25(1):190-4. PubMed ID: 8985289
[TBL] [Abstract][Full Text] [Related]
35. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
[TBL] [Abstract][Full Text] [Related]
36. Role of HLA antigens in liver transplantation with special reference to cellular immune reactions.
Markus BH; Duquesnoy RJ; Blaheta RA; Scholz M; Encke A
Langenbecks Arch Surg; 1998 Mar; 383(1):87-94. PubMed ID: 9627177
[TBL] [Abstract][Full Text] [Related]
37. Role of Human Leukocyte Antigen Compatibility in Graft Outcomes After Living Donor Liver Transplantation.
Shin M; Kim JM; Kwon CH; Kim SJ; Joh JW
Transplant Proc; 2016 May; 48(4):1123-9. PubMed ID: 27320571
[TBL] [Abstract][Full Text] [Related]
38. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".
Donaldson P; Underhill J; Doherty D; Hayllar K; Calne R; Tan KC; O'Grady J; Wight D; Portmann B; Williams R
Hepatology; 1993 Jun; 17(6):1008-15. PubMed ID: 8514248
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus infection as a possible risk factor for ductopenic rejection (vanishing bile duct syndrome) after liver transplantation.
Hoffmann RM; Günther C; Diepolder HM; Zachoval R; Eissner HJ; Forst H; Anthuber M; Paumgartner G; Pape GR
Transpl Int; 1995; 8(5):353-9. PubMed ID: 7576016
[TBL] [Abstract][Full Text] [Related]
40. Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch.
Sheldon S; Hasleton PS; Yonan NA; Rhaman AN; Deiraniya AK; Campbell CS; Brooks NH; Dyer PA
Transplantation; 1994 Sep; 58(6):719-22. PubMed ID: 7940693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
